Skip to content

Pre-Tax Income at other companies

Cabot Corporation logo
Cabot CorporationCBT
$120M-20.5%
Unifirst logo
UnifirstUNF
$27.34M-16.2%
Travel + Leisure logo
Travel + LeisureTNL
$108M+6.9%
HES
Hess MidstreamHESM
$185.9M+0.8%
Dave, Inc. logo
Dave, Inc.DAVE
$70.16M+107%
MYR Group logo
MYR GroupMYRG
$64.03M+95.4%

Segments

By segment

See full
United States$610.7M+9.2%
Europe$235.3M+21.0%
Rest of World$89.7M+15.7%
Japan$66.4M+15.1%

Other financials

Income statement

See full
Revenue$1.6B+16.7%
Gross profit$1.3B+15.7%
Operating income$477.6M+21.0%
Net income$380.7M+6.3%
EPS (diluted)$0.66+8.2%

Balance sheet

See full
Cash & equivalents$2.4B-22.3%
Total debt$702.9M+0.5%
Total equity$10.3B+2.0%
Total assets$13.3B+2.3%

Cash flow

See full
Operating cash flow$43.8M-84.4%
CapEx$64.9M+15.9%
Free cash flow-$21.1M-109%

Valuation

See full
Market cap$51.66B+19.3%
Enterprise value$49.92B+22.2%
P/E47.1×+36.8×
P/S8.2×+0.4×

Profitability

See full
Gross margin77.9%-1.6pp
Operating margin21.4%-4.4pp
Net margin17.4%-58.3pp
FCF margin17.3%

Returns & leverage

See full
Return on equity10.7%-37.8pp
Debt / equity0.1×0.0×
Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edwards Lifesciences's pre-tax income?
Edwards Lifesciences (EW) reported pre-tax income of $459M in Q1 2026.
How has Edwards Lifesciences's pre-tax income changed year-over-year?
Edwards Lifesciences's pre-tax income increased by 5.8% year-over-year, from $433.9M to $459M.
What is the long-term trend for Edwards Lifesciences's pre-tax income?
Over 4 years (2021 to 2025), Edwards Lifesciences's pre-tax income has grown at a -7.0% compound annual growth rate (CAGR), from $1.7B to $1.27B.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.